UnitedHealth Group Incorporated $UNH Stock: Aberdeen Group plc Reduces Stake

Aberdeen Group plc lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 63.6% in the 3rd quarter, Holdings Channel.com reports. The firm owned 376,331 shares of the healthcare conglomerate’s stock after selling 656,137 shares during the quarter. Aberdeen Group plc’s holdings in UnitedHealth Group were worth $138,144,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in UNH. General Partner Inc. acquired a new position in UnitedHealth Group in the third quarter valued at about $512,000. PBCay One RSC Ltd bought a new stake in shares of UnitedHealth Group during the first quarter worth $14,343,000. Lee Johnson Capital Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at about $6,180,000. Kinsale Capital Group Inc. boosted its stake in UnitedHealth Group by 13.4% in the second quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock valued at $16,006,000 after acquiring an additional 4,557 shares during the last quarter. Finally, Kelleher Financial Advisors boosted its holdings in UnitedHealth Group by 135.9% during the second quarter. Kelleher Financial Advisors now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,284,000 after buying an additional 3,166 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Latest UnitedHealth Group News

These are some of the UNH news items that stood out recently:

• Positive Sentiment: Optum Rx reported higher operating earnings in the third quarter of 2026 despite lower prescription volumes. Biosimilar adoption and operating efficiencies helped offset pressure, demonstrating the segment’s ability to grow profitability amid membership challenges. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?
• Positive Sentiment: ETF flows were supportive: 51 ETFs bought UNH while nine sold shares on Nov. 11, for reported net ETF buying of $86.8 million. Article: UnitedHealth Sees $86.8 Million in Net ETF Buying
• Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $2.49 on Friday, reaching $407.62. 3,467,004 shares of the stock were exchanged, compared to its average volume of 5,162,694. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a market cap of $365.23 billion, a PE ratio of 23.28, a P/E/G ratio of 1.47 and a beta of 0.51. The firm’s 50 day moving average is $391.36 and its 200-day moving average is $365.66. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter last year, the company posted $2.59 EPS. The company’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on UNH shares. JPMorgan Chase & Co. boosted their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a report on Friday, October 16th. Bank of America reaffirmed a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a research note on Monday, July 20th. Morgan Stanley upped their target price on UnitedHealth Group from $529.00 to $531.00 and gave the stock an “overweight” rating in a report on Tuesday, October 27th. Argus increased their price target on shares of UnitedHealth Group from $400.00 to $470.00 and gave the company a “buy” rating in a research note on Monday, July 20th. Finally, UBS Group reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.19% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.